|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
B
|
|
INDICATIONS:
|
|
|
|
SIDE EFFECTS:
|
|
Abnormal dreams |
|
asthenia |
|
corneal infiltrates or staining |
|
keratitis |
|
tearing , discomfort , or other eye irritation not present before therapy or becoming worse during therapy |
|
Headache |
|
Bad taste |
|
burning or stinging of the eye |
|
dermatitis |
|
dry eye |
|
foreign body sensation |
|
hyperemia |
|
pruritis |
|
rhinitis |
|
sinusitis |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
|
|
ADULT DOSE:
|
|
Allergic conjunctivitis-
Topical, to the conjunctiva, 1 drop in each affected eye up to four times a day . |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Allergic conjunctivitis-
Children younger than 3 years of age: Safety and efficacy have not been established .
Children 3 years of age and older: See Usual adult and adolescent dose. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|